A Phase 1 Study To Evaluate the Safety of Migalastat Hydrochloride Given Intravenously to Healthy Volunteers
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of IV
migalastat HCl alone and to determine absolute bioavailability for oral migalastat HCl as
compared to IV administered migalastat HCl in healthy volunteers. The data from this study
will help us understand how migalastat works in the body and will help us determine what
would be an effective dose in future studies with migalastat hydrochloride.